Acasti Pharma Number of Employees 2014-2024 | GRCE
Acasti Pharma number of employees from 2014 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Acasti Pharma Annual Employee Count |
| 2024 |
4 |
| 2023 |
|
| 2022 |
|
| 2021 |
|
| 2020 |
32 |
| 2019 |
28 |
| 2018 |
24 |
| 2017 |
15 |
| 2016 |
11 |
| 2015 |
|
| 2015 |
7 |
| 2014 |
|
| 2014 |
6 |
| 2013 |
|
| 2013 |
10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.033B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
